Genetics of erectile dysfunction: A review of the interface between sex and molecular biomarkers

Journal of Sexual Medicine

Volumn 8, Issue 11, 2011, Pages 3030-3039

  Andersen, Monica L ^a   Guindalini, Camila ^a   Tufik, Sergio ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Erectile dysfunction; Genetic assays; Hormones; Polymorphisms

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; LOSARTAN; MARKER; METHYLENETETRAHYDROFOLIC ACID; MOLECULAR MARKER; PROGESTERONE; SEX MARKER; SILDENAFIL; TESTOSTERONE; UNCLASSIFIED DRUG;

CARDIOVASCULAR DISEASE; DRUG EFFICACY; DRUG MECHANISM; ERECTILE DYSFUNCTION; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENETICS; HETEROZYGOTE; HUMAN; INDEL MUTATION; MOLECULAR GENETICS; PHENOTYPE; POPULATION RESEARCH; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SEXUAL BEHAVIOR; SIGNAL TRANSDUCTION; TREATMENT RESPONSE;

EID: 80255138847     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2011.02422.x     Document Type: Review

References (82)

1. Smith JF, Caan BJ, Sternfeld B, Haque R, Quesenberry CP Jr., Quinn VP, Shan J, Walsh TJ, Lue TF, Jacobsen SJ, Van Den Eeden SK. Racial disparities in erectile dysfunction among participants in the California Men's Health Study. J Sex Med 2009;6:3433-9.
2. Corona G, Lee DM, Forti G, O'Connor DB, Maggi M, O'Neill TW, Pendleton N, Bartfai G, Boonen S, Casanueva FF, Finn JD, Giwercman A, Han TS, Huhtaniemi IT, Kula K, Lean ME, Punab M, Silman AJ, Vanderschueren D, Wu FC. Age-related changes in general and sexual health in middle-aged and older men: Results from the European Male Ageing Study (EMAS). J Sex Med 2010;7:1362-80.
3. Burnett AL. Erectile dysfunction. J Urol 2006;175:S25-31.
4. Lewis RW, Fugl-Meyer KS, Bosch R, Fugl-Meyer AR, Laumann EO, Lizza E, Martin-Morales A. Epidemiology/risk factors of sexual dysfunction. J Sex Med 2004;1:35-9.
5. Andersen ML, Santos-Silva R, Bittencourt LR, Tufik S. Prevalence of erectile dysfunction complaints associated with sleep disturbances in Sao Paulo, Brazil: A population-based survey. Sleep Med 2010;10:1019-24.
6. Hatzimouratidis K, Amar E, Eardley I, Giuliano F, Hatzichristou D, Montorsi F, Vardi Y, Wespes E; European Association of Urology. Guidelines on male sexual dysfunction: Erectile dysfunction and premature ejaculation. Eur Urol 2010;57:804-14.
7. Hingorani AD, Shah T, Kumari M, Sofat R, Smeeth L. Translating genomics into improved healthcare. BMJ 2010;341:c5945.
8. Reich DE, Lander ES. On the allelic spectrum of human disease. Trends Genet 2001;17:502-10.
9. Ralph D, McNicholas T. UK management guidelines for erectile dysfunction. BMJ 2000;321:499-503.
10. Klein RJ. Power analysis for genome-wide association studies. BMC Genet 2007;8:58.
11. Xie HG, Dishy V, Sofowora G, Kim RB, Landau R, Smiley RM, Zhou HH, Wood AJ, Harris P, Stein CM. Arg389Gly beta 1-adrenoceptor polymorphism varies in frequency among different ethnic groups but does not alter response in vivo. Pharmacogenetics 2001;11:191-7.
12. Rosenberg NA, Pritchard JK, Weber JL, Cann HM, Kidd KK, Zhivotovsky LA, Feldman MW. Genetic structure of human populations. Science 2002;298:2381-5.
13. Abdel-Hamid IA, Andersson KE. Pharmacogenetics and pharmacogenomics of sexual dysfunction: Current status, gaps and potential applications. Pharmacogenomics 2009;10:1625-44.
14. Shi L, Mao C, Xu Z, Zhang L. Angiotensin-converting enzymes and drug discovery in cardiovascular diseases. Drug Discov Today 2010;15:332-41.
15. Kloner RA. Erectile dysfunction as a predictor of cardiovascular disease. Int J Impot Res 2008;20:460-5.
16. Ljungberg L, Alehagen U, Länne T, Björck H, De Basso R, Dahlström U, Persson K. The association between circulating angiotensin-converting enzyme and cardiovascular risk in the elderly: A cross-sectional study. J Renin Angiotensin Aldosterone Syst 2011 Jan 27 [Epub ahead of print] doi: 10.1177/1470320310391326.
17. Becker AJ, Uckert S, Stief CG, Scheller F, Knapp WH, Hartmann U, Jonas U. Plasma levels of angiotensin II during different penile conditions in the cavernous and systemic blood of healthy men and patients with erectile dysfunction. Urology 2001;58:805-10.
18. Yang R, Yang B, Wen Y, Fang F, Cui S, Lin G, Sun Z, Wang R, Dai Y. Losartan, an angiotensin type I receptor, restores erectile function by downregulation of cavernous renin-angiotensin system in streptozocin-induced diabetic rats. J Sex Med 2009;6:696-707.
19. Mollsten A, Stegmayr B, Wiklund PG. Genetic polymorphisms in the renin-angiotensin system confer increased risk of stroke independently of blood pressure: A nested case-control study. J Hypertens 2008;26:1367-72.
20. Wiwanitkit V. I/D genetic polymorphism of angiotensin-converting enzyme: Pathogenesis evaluation for erectile dysfunction by gene ontology. Fertil Steril 2008;89:1095-7.
21. Park JK, Kim W, Kim SW, Koh GY, Park SK. Gene polymorphisms of angiotensin converting enzyme and endothelial nitric oxide synthase in patients with erectile dysfunction. Int J Impot Res 1999;11:273-6.
22. Kim DS, Choi SI, Lee HS, Park JK, Yi HK. Determination of human angiotensin converting enzyme (ACE) gene polymorphisms in erectile dysfunction: Frequency differences of ACE gene polymorphisms according to the method of analysis. Clin Chem Lab Med 2001;39:11-4.
23. Eisenhardt A, Sperling H, Hauck E, Porst H, Stief C, Rübben H, Müller N, Siffert W. ACE gene I/D and NOS3 G894T polymorphisms and response to sildenafil in men with erectile dysfunction. Urology 2003;62:152-7.
24. Rosas-Vargas H, Coral-Vazquez RM, Tapia R, Borja JL, Salas RA, Salamanca F. Glu298Asp endothelial nitric oxide synthase polymorphism is a risk factor for erectile dysfunction in the Mexican Mestizo population. J Androl 2004;25:728-32.
25. Mazo EB, Gamidov SI, Mamedov MN, Iremashvili VV. Association between the insertion/deletion polymorphism of the angiotensin-converting enzyme gene and erectile dysfunction in patients with metabolic syndrome. Int J Impot Res 2008;20:68-72.
26. Eisenhardt A, Stief C, Porst H, Wetterauer U, Weidner W, Rübben H, Sperling H. Genetic association study of the GNB3 C825T, the ACE I/D and the eNOS G894T polymorphisms and the risk to develop erectile dysfunction in a German ED population. Andrologia 2010;42:218-24.
27. Andersen ML, Guindalini C, Santos-Silva R, Bittencourt LR, Tufik S. Angiotensin-converting enzyme polymorphism and erectile dysfunction complaints in the Brazilian population. J Sex Med 2010;7:2791-7.
28. Burnett AL, Ricker DD, Chamness SL, Maguire MP, Crone JK, Bredt DS, Snyder SH, Chang TS. Localization of nitric oxide synthase in the reproductive organs of the male rat. Biol Reprod 1995;52:1-7.
29. Lasker GF, Maley JH, Kadowitz PJ. A review of the pathophysiology and novel treatments for erectile dysfunction. Adv Pharmacol Sci 2010 [Epub ahead of print] doi: 10.1155/2010/730861.
30. Lee YC, Huang CH, Wang CJ, Liu CC, Wu WJ, Chang LL, Lin HH. The associations among eNOS G894T gene polymorphism, erectile dysfunction and related risk factors. BJU Int 2007;100:1116-20.
31. Lee YC, Wu WJ, Liu CC, Wang CJ, Li WM, Huang CH, Yeh HC, Ke HL, Huang SP. The associations among eNOS G894T gene polymorphism, erectile dysfunction, and benign prostate hyperplasia-related lower urinary tract symptoms. J Sex Med 2009;6:3158-65.
32. Erol B, Bozdogan G, Akduman B, Dursun A, Bozdogan S, Onem K, Mungan A. eNOS gene intron 4 VNTR and exon 7-G894T polymorphisms in Turkish men with erectile dysfunction: A case control study. J Sex Med 2009;6:1423-9.
33. Safarinejad MR, Khoshdel A, Shekarchi B, Taghva A, Safarinejad S. Association of the T-786C, G894T and 4a/4b polymorphisms of the endothelial nitric oxide synthase gene with vasculogenic erectile dysfunction in Iranian subjects. BJU Int 2011;107:1994-2001.
34. Andersen ML, Guindalini C, Santos-Silva R, Bittencourt LR, Tufik S. Association analysis of endothelial nitric oxide synthase G894T gene polymorphism and erectile dysfunction complaints in a population-based survey. J Sex Med 2010;7:1229-36.
35. Shabsigh R, Anastasiadis AG. Erectile dysfunction. Annu Rev Med 2003;54:153-68.
36. Dosenko VE, Zagoriy VY, Haytovich NV, Gordok OA, Moibenko AA. Allelic polymorphism of endothelial NO-synthase gene and its functional manifestations. Acta Biochim Pol 2006;53:299-302.
37. Sinici I, Güven EO, Serefoǧlu E, Hayran M. T-786C polymorphism in promoter of eNOS gene as genetic risk factor in patients with erectile dysfunction in Turkish population. Urology 2010;75:955-60.
38. Meluzin J, Vasku A, Kincl V, Panovsky R, Sramkova T. Association of coronary artery disease, erectile dysfunction, and endothelial nitric oxide synthase polymorphisms. Heart Vessels 2009;24:157-63.
39. Song J, Yoon Y, Park KU, Park J, Hong YJ, Hong SH, Kim JQ. Genotype-specific influence on nitric oxide synthase gene expression, protein concentrations, and enzyme activity in cultured human endothelial cells. Clin Chem 2003;49:847-52.
40. Erkan E, Muslumanoglu AY, Oktar T, Sanli O, Ozbek U, Kadioglu A. Polymorphism of endothelial nitric oxide synthase gene in patients with erectile dysfunction. J Sex Med 2006;3:69-75.
41. Siffert W. G protein polymorphisms in hypertension, atherosclerosis, and diabetes. Annu Rev Med 2005;56:17-28.
42. Virchow S, Ansorge N, Rosskopf D, Rubben H, Siffert W. The G protein beta3 subunit splice variant Gbeta3-s causes enhanced chemotaxis of human neutrophils in response to interleukin-8. Naunyn Schmiedebergs Arch Pharmacol 1999;360:27-32.
43. Lee YC, Lin HH, Wang CJ, Liu CC, Wu WJ, Huang CH, Chang LL. The associations among GNB3 C825T polymorphism, erectile dysfunction, and related risk factors. J Sex Med 2008;5:2061-8.
44. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP, Rozen R. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10:111-3.
45. Austin RC, Lentz SR, Werstuck GH. Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease. Cell Death Differ 2004;11S1:S56-64.
46. Demir T, Comlekci A, Demir O, Gulcu A, Calypkan S, Argun L, Secil M, Yepil S, Esen A. Hyperhomocysteinemia: A novel risk factor for erectile dysfunction. Metabolism 2006;55:1564-8.
47. Kang SS, Wong PW, Zhou JM, Sora J, Lessick M, Ruggie N, Grcevich G. Thermolabile methylenetetrahydrofolate reductase in patients with coronary artery disease. Metabolism 1988;37:611-3.
48. Weisberg I, Tran P, Christensen B, Sibani S, Rozen R. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 1998;64:169-72.
49. Rady PL, Szucs S, Grady J, Hudnall SD, Kellner LH, Nitowsky H, Tyring SK, Matalon RK. Genetic polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) in ethnic populations in Texas; a report of a novel MTHFR polymorphic site, G1793A. Am J Med Genet 2002;107:162-8.
50. Safarinejad MR, Safarinejad S, Shafiei N. Role of methylenetetrahydrofolate reductase gene polymorphisms (C677T, A1298C, and G1793A) in the development of early onset vasculogenic erectile dysfunction. Arch Med Res 2010;41:410-22.
51. Paredes RG, Agmo A. Has dopamine a physiological role in the control of sexual behavior? A critical review of the evidence. Prog Neurobiol 2004;73:179-226.
52. Ben Zion IZ, Tessler R, Cohen L, Lerer E, Raz Y, Bachner-Melman R, Gritsenko I, Nemanov L, Zohar AH, Belmaker RH, Benjamin J, Ebstein RP. Polymorphisms in the dopamine D4 receptor gene (DRD4) contribute to individual differences in human sexual behavior: Desire, arousal and sexual function. Mol Psychiatry 2006;11:782-6.
53. Montorsi F, Oettel M. Testosterone and sleep-related erections: An overview. J Sex Med 2005;2:771-84.
54. Traish AM, Goldstein I, Kim NN. Testosterone and erectile function: From basic research to a new clinical paradigm for managing men with androgen insufficiency and erectile dysfunction. Eur Urol 2007;52:54-70.
55. Andersen ML, Tufik S. The effects of testosterone on sleep and sleep-disordered breathing in men: Its bidirectional interaction with erectile function. Sleep Med Rev 2008;12:365-79.
56. Andrew SE, Goldberg YP, Hayden MR. Rethinking genotype and phenotype correlations in polyglutamine expansion disorders. Hum Mol Genet 1997;6:2005-10.
57. Chamberlain NL, Driver ED, Miesfeld RL. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res 1994;22:3181-6.
58. Beilin J, Ball EM, Favaloro JM, Zajac JD. Effect of the androgen receptor CAG repeat polymorphism on transcriptional activity: Specificity in prostate and non-prostate cell lines. J Mol Endocrinol 2000;25:85-96.
59. Huhtaniemi IT, Pye SR, Limer KL, Thomson W, O'Neill TW, Platt H, Payne D, John SL, Jiang M, Boonen S, Borghs H, Vanderschueren D, Adams JE, Ward KA, Bartfai G, Casanueva F, Finn JD, Forti G, Giwercman A, Han TS, Kula K, Lean ME, Pendleton N, Punab M, Silman AJ, Wu FC. Increased estrogen rather than decreased androgen action is associated with longer androgen receptor CAG repeats. J Clin Endocrinol Metab 2009;94:277-84.
60. Loy CJ, Yong EL. Sex, infertility and the molecular biology of the androgen receptor. Curr Opin Obstet Gynecol 2001;13:315-21.
61. Zitzmann M, Nieschlag E. The CAG repeat polymorphism within the androgen receptor gene and maleness. Int J Androl 2003;26:76-83.
62. Davis-Dao CA, Tuazon ED, Sokol RZ, Cortessis VK. Male infertility and variation in CAG repeat length in the androgen receptor gene: A meta-analysis. J Clin Endocrinol Metab 2007;92:4319-26.
63. Andersen ML, Guindalini C, Santos-Silva R, Bittencourt LR, Tufik S. Androgen receptor CAG repeat polymorphism is not associated with erectile dysfunction complaints, gonadal steroids and sleep parameters: Data from a population-based survey. J Androl 2010 Dec 30 [Epub ahead of print] doi: 10.2164/jandrol.110.012013.
64. Andersen ML, Bignotto M, Machado RB, Tufik S. Does paradoxical sleep deprivation and cocaine induce penile erection and ejaculation in old rats? Addict Biol 2002;7:285-90.
65. Andersen ML, Bignotto M, Tufik S. Hormone treatment facilitates penile erection in castrated rats after sleep deprivation and cocaine. J Neuroendocrinol 2004;16:154-9.
66. Andersen ML, Tufik S. Does male sexual behavior require progesterone? Brain Res Rev 2006;51:136-43.
67. Alvarenga TA, Andersen ML, Tufik S. Influence of progesterone on sexual performance in male rats. J Sex Med 2010;7:2435-44.
68. Romano A, Delvoux B, Fischer DC, Groothuis P. The PROGINS polymorphism of the human progesterone receptor diminishes the response to progesterone. J Mol Endocrinol 2007;38:331-50.
69. Modugno F. Ovarian cancer and polymorphisms in the androgen and progesterone receptor genes: A HuGE review. Am J Epidemiol 2004;159:319-35.
70. Junqueira MG, da Silva ID, Nogueira-de-Souza NC, Carvalho CV, Leite DB, Gomes MT, Baracat EC, Lopes LA, Nicolau SM, Gonçalves WJ. Progesterone receptor (PROGINS) polymorphism and the risk of endometrial cancer development. Int J Gynecol Cancer 2007;17:229-32.
71. Leite DB, Junqueira MG, de Carvalho CV, Massad-Costa AM, Gonçalves WJ, Nicolau SM, Lopes LA, Baracat EC, da Silva ID. Progesterone receptor (PROGINS) polymorphism and the risk of ovarian cancer. Steroids 2008;73:676-80.
72. Fukatsu T, Hirokawa Y, Araki T, Hioki T, Murata T, Suzuki H, Ichikawa T, Tsukino H, Qiu D, Katoh T, Sugimura Y, Yatani R, Shiraishi T, Watanabe M. Genetic polymorphisms of hormone-related genes and prostate cancer risk in the Japanese population. Anticancer Res 2004;24:2431-7.
73. Andersen ML, Alvarenga TA, Mazzotti DR, Guindalini C, Pellegrino R, Barrueco KF, Santos-Silva R, Bittencourt LR, Tufik S. Hormonal profile, the PROGINS polymorphism, and erectile dysfunction complaints: Data from a population-based survey. Fertil Steril 2011;95:621-4.
74. Daly AK. Pharmacogenetics and human genetic polymorphisms. Biochem J 2010;429:435-49.
75. Spear BB, Heath-Chiozzi M, Huff J. Clinical application of pharmacogenetics. Trends Mol Med 2001;7:201-4.
76. Eichelbaum M, Ingelman-Sundberg M, Evans WE. Pharmacogenomics and individualized drug therapy. Annu Rev Med 2006;57:119-37.
77. Eisenhardt A, Siffer TW. Genetic risk factors for erectile dysfunction and genetic determinants of drug response-On the way to improve drug safety? Herz 2003;28:304-13.
78. Sperling H, Eisenhardt A, Virchow S, Hauck E, Lenk S, Porst H, Stief C, Wetterauer U, Rubben H, Muller N, Siffert W. Sildenafil response is influenced by the G protein beta 3 subunit GNB3 C825T polymorphism: A pilot study. J Urol 2003;169:1048-51.
79. Peskircioglu L, Atac FB, Erdem SR, Deveci S, Verdi H, Ozkardes H. The association between intron 4 VNTR, E298A and IVF 23+10 G/T polymorphisms of ecNOS gene and sildenafil responsiveness in patients with erectile dysfunction. Int J Impot Res 2007;19:149-53.
80. Wang JL, Wang HG, Gao HQ, Zhai GX, Chang P, Chen YG. Endothelial nitric oxide synthase polymorphisms and erectile dysfunction: A meta-analysis. J Sex Med 2010;7:3889-98.
81. Burnett AL, Goldstein I, Andersson KE, Argiolas A, Christ G, Park K, Xin ZC. Future sexual medicine physiological treatment targets. J Sex Med 2010;7:3269-304.
82. Pritchard JK, Donnelly P. Case-control studies of association in structured or admixed populations. Theor Popul Biol 2001;60:227-37.